Metoclopramide
Gimoti, Reglan (metoclopramide) is a small molecule pharmaceutical. Metoclopramide was first approved as Reglan on 1982-01-01. It is used to treat gastroesophageal reflux, gastroparesis, and postoperative nausea and vomiting in the USA. The pharmaceutical is active against 5-hydroxytryptamine receptor 4 and D(2) dopamine receptor. In addition, it is known to target 5-hydroxytryptamine receptor 3A.
Download report
Favorite
Commercial
Trade Name
FDA
EMA
Gimoti, Reglan (generic drugs available since 1985-07-29, discontinued: Clopra, Clopra-yellow, Maxolon, Metozolv)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Labels
FDA
EMA
Brand Name | Status | Last Update |
---|---|---|
gimoti | New Drug Application | 2021-01-07 |
metoclopramide | ANDA | 2023-06-07 |
reglan | New Drug Application | 2020-06-19 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
gastroesophageal reflux | EFO_0003948 | D005764 | K21 |
gastroparesis | EFO_1000948 | D018589 | K31.84 |
postoperative nausea and vomiting | EFO_0004888 | D020250 | — |
Agency Specific
FDA
EMA
Expiration | Code | ||
---|---|---|---|
METOCLOPRAMIDE HYDROCHLORIDE, GIMOTI, EVOKE PHARMA INC | |||
2023-06-19 | NP |
HCPCS
Code | Description |
---|---|
J2765 | Injection, metoclopramide hcl, up to 10 mg |
Clinical
Clinical Trials
127 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Migraine disorders | D008881 | EFO_0003821 | G43 | — | 2 | 5 | 8 | 3 | 18 |
Vomiting | D014839 | HP_0002013 | R11.1 | 1 | 2 | 6 | 7 | 1 | 17 |
Nausea | D009325 | HP_0002018 | R11.0 | — | — | 3 | 8 | 2 | 13 |
Headache | D006261 | HP_0002315 | R51 | — | 1 | 3 | 1 | 1 | 5 |
Neoplasms | D009369 | C80 | — | — | 2 | 1 | 1 | 4 | |
Postoperative nausea and vomiting | D020250 | EFO_0004888 | — | — | 1 | 1 | 1 | 3 | |
Post-traumatic headache | D051298 | G44.3 | 1 | 1 | 1 | 1 | — | 3 | |
Vertigo | D014717 | H81.39 | — | — | 1 | 1 | — | 2 | |
Psychomotor agitation | D011595 | — | — | — | 1 | 1 | 2 | ||
Gastroesophageal reflux | D005764 | EFO_0003948 | K21 | — | — | 1 | 1 | — | 2 |
Show 22 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Gastroparesis | D018589 | EFO_1000948 | K31.84 | — | 2 | 2 | — | 1 | 5 |
Breast feeding | D001942 | — | — | 1 | — | 1 | 2 | ||
Myeloid leukemia acute | D015470 | C92.0 | — | — | 1 | — | — | 1 | |
Hiv infections | D015658 | EFO_0000764 | B20 | — | — | 1 | — | — | 1 |
Gastroschisis | D020139 | EFO_1000949 | Q79.3 | — | — | 1 | — | — | 1 |
Sepsis | D018805 | A41.9 | — | — | 1 | — | — | 1 | |
Anemia | D000740 | EFO_0004272 | D64.9 | — | — | 1 | — | — | 1 |
Gastrointestinal hemorrhage | D006471 | K92.2 | — | — | 1 | — | — | 1 | |
Intraoperative complications | D007431 | — | — | 1 | — | — | 1 |
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | — | 2 | — | — | — | 2 |
Hyperemesis gravidarum | D006939 | EFO_1000971 | O21 | — | 2 | — | — | — | 2 |
Enteral nutrition | D004750 | — | 2 | — | — | — | 2 | ||
Hypoglycemia | D007003 | HP_0001943 | E16.2 | — | 1 | — | — | — | 1 |
Myelodysplastic syndromes | D009190 | D46 | — | 1 | — | — | — | 1 | |
Drug-related side effects and adverse reactions | D064420 | T88.7 | — | 1 | — | — | — | 1 | |
Wounds and injuries | D014947 | T14.8 | — | 1 | — | — | — | 1 | |
Radiation exposure | D000069079 | — | 1 | — | — | — | 1 | ||
Newborn infant diseases | D007232 | — | 1 | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hypotension | D007022 | EFO_0005251 | I95 | — | — | — | — | 2 | 2 |
Rhytidoplasty | D015361 | — | — | — | — | 1 | 1 | ||
Fertilization in vitro | D005307 | — | — | — | — | 1 | 1 | ||
Obesity | D009765 | EFO_0001073 | E66.9 | — | — | — | — | 1 | 1 |
Pregnancy rate | D018873 | — | — | — | — | 1 | 1 | ||
Deglutition disorders | D003680 | HP_0002015 | R13.1 | — | — | — | — | 1 | 1 |
Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | — | — | — | — | 1 | 1 |
Colorectal neoplasms | D015179 | — | — | — | — | 1 | 1 | ||
Hyperlactatemia | D065906 | — | — | — | — | 1 | 1 | ||
Altitude sickness | D000532 | EFO_1000782 | T70.29 | — | — | — | — | 1 | 1 |
Show 3 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | METOCLOPRAMIDE |
INN | metoclopramide |
Description | Metoclopramide is a member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine. It has a role as an antiemetic, a dopaminergic antagonist, a gastrointestinal drug, a xenobiotic and an environmental contaminant. It is a tertiary amino compound, a substituted aniline, a member of benzamides and a member of monochlorobenzenes. It is a conjugate base of a metoclopramide(1+). |
Classification | Small molecule |
Drug class | D2 receptor antagonist; 5-HT3 receptor antagonist; 5-HT4 receptor agonist; Prolactin releaser |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC |
Identifiers
PDB | — |
CAS-ID | 364-62-5 |
RxCUI | 6915 |
ChEMBL ID | CHEMBL86 |
ChEBI ID | 107736 |
PubChem CID | 4168 |
DrugBank | DB01233 |
UNII ID | L4YEB44I46 (ChemIDplus, GSRS) |
Target
Agency Approved
HTR4
HTR4
DRD2
DRD2
Alternate
HTR3A
HTR3A
Organism
Homo sapiens
Gene name
HTR3A
Gene synonyms
5HT3R, HTR3
NCBI Gene ID
Protein name
5-hydroxytryptamine receptor 3A
Protein synonyms
5-HT-3, 5-HT3R, 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic, 5-hydroxytryptamine receptor 3, 5HT3 serotonin receptor, Serotonin receptor 3A, Serotonin-gated ion channel receptor
Uniprot ID
Mouse ortholog
Htr3a (15561)
5-hydroxytryptamine receptor 3A (Q61226)
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 11,907 documents
View more details
Safety
Black-box Warning
Black-box warning for: Gimoti, Metoclopramide, Reglan
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
5,001 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more